Basic Information
| LncRNA/CircRNA Name | lnc01133 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qRT-PCR, Western blot assays |
| Sample | human ovarian cancer cell lines (A2780, Caov3, HO-8910, OVCAR3, and SKOV3) and a human ovarian epithelial cell line (HOEpiC) |
| Expression Pattern | up-regulated |
| Function Description | LNC01133 was related to poor survival of OC patients, and identified that LNC01133 had significant influence on OC cells' apoptosis, proliferation, migration and invasion abilities. |
| Pubmed ID | 31949667 |
| Year | 2018 |
| Title | Long Non-Coding RNA LNC01133 Promotes the Tumorigenesis of Ovarian Cancer by Sponging miR-126 |
External Links
| Links for lnc01133 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |